These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3260051)

  • 1. Cyclosporine A and cyclosporine G enhance IgG rheumatoid factor production in MRL/lpr mice.
    Gunn HC; Hiestand PC
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):238-42. PubMed ID: 3260051
    [No Abstract]   [Full Text] [Related]  

  • 2. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclosporin A on autoimmune disease in MRL/1 and BXSB mice.
    Berden JH; Faaber P; Assmann KJ; Rijke TP
    Scand J Immunol; 1986 Oct; 24(4):405-11. PubMed ID: 3489984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice.
    Santoro TJ; Portanova JP; Kotzin BL
    J Exp Med; 1988 May; 167(5):1713-8. PubMed ID: 3259258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice.
    Gyotoku Y; Abdelmoula M; Spertini F; Izui S; Lambert PH
    J Immunol; 1987 Jun; 138(11):3785-92. PubMed ID: 3495570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the role of the lpr gene in the development of immunological abnormalities and lupus nephritis. Analyses in F2 mice.
    Fujiwara M; Kariyone A; Shiraki M
    Clin Exp Immunol; 1985 Jan; 59(1):161-8. PubMed ID: 3918816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
    Fan JL; Himeno K; Tsuru S; Nomoto K
    Clin Exp Immunol; 1987 Oct; 70(1):94-101. PubMed ID: 3500817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.
    Ma J; Xu J; Madaio MP; Peng Q; Zhang J; Grewal IS; Flavell RA; Craft J
    J Immunol; 1996 Jul; 157(1):417-26. PubMed ID: 8683147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotype progression and clonality of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.
    Eisenberg RA; Craven SY; Cohen PL
    J Immunol; 1987 Aug; 139(3):728-33. PubMed ID: 3474277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior and immune status of MRL mice in the postweaning period.
    Sakić B; Szechtman H; Talangbayan H; Denburg S; Carbotte R; Denburg JA
    Brain Behav Immun; 1994 Mar; 8(1):1-13. PubMed ID: 8003767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
    J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG antinuclear antibodies with cross-reactive rheumatoid factor activity.
    Darwin BS; Grudier JP; Klatt CL; Pisetsky DS
    J Immunol; 1986 Dec; 137(12):3796-801. PubMed ID: 3782796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
    Ratkay LG; Tait B; Tonzetich J; Waterfield JD
    J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
    Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R
    J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enforced Bcl-2 expression in B lymphocytes induces rheumatoid factor and anti-DNA production, but the Yaa mutation promotes only anti-DNA production.
    Kuroki A; Moll T; López-Hoyos M; Fossati-Jimack L; Ibnou-Zekri N; Kikuchi S; Merino J; Merino R; Izui S
    Eur J Immunol; 2004 Apr; 34(4):1077-84. PubMed ID: 15048718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
    Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
    Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
    J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.